We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 11.38%
3 Technology 10.34%
4 Industrials 9.82%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTE icon
376
Astec Industries
ASTE
$1.16B
$1.99M 0.06%
29,474
+914
+3% +$57.1K
XLE icon
377
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$1.97M 0.06%
52,312
+19,154
+58% +$693K
MHG
378
DELISTED
Marine Harvest ASA
MHG
$1.97M 0.06%
108,385
+1,949
+2% +$34.9K
RF icon
379
Regions Financial
RF
$26.4B
$1.96M 0.06%
136,617
-5,194
-4% -$64.2K
BIDU icon
380
Baidu
BIDU
$37.7B
$1.96M 0.06%
11,910
+1,274
+12% +$217K
IGV icon
381
iShares Expanded Tech-Software Sector ETF
IGV
$12.7B
$1.96M 0.06%
89,890
-11,185
-11% -$250K
EWJ icon
382
iShares MSCI Japan ETF
EWJ
$21.9B
$1.95M 0.06%
39,819
-13,010
-25% -$650K
RVT icon
383
Royce Value Trust
RVT
$2.21B
$1.95M 0.06%
145,319
+20,095
+16% +$258K
VYM icon
384
Vanguard High Dividend Yield ETF
VYM
$80.9B
$1.95M 0.06%
25,683
-13,248
-34% -$972K
VRNT
385
DELISTED
Verint Systems
VRNT
$1.93M 0.06%
107,184
+40,236
+60% +$748K
UDR icon
386
UDR
UDR
$12.3B
$1.91M 0.06%
52,406
-1,051
-2% -$36K
CMG icon
387
Chipotle Mexican Grill
CMG
$47.2B
$1.91M 0.06%
253,100
+57,750
+30% +$456K
EW icon
388
Edwards Lifesciences
EW
$49.6B
$1.91M 0.06%
61,182
-124,134
-67% -$4.02M
TSN icon
389
Tyson Foods
TSN
$20.4B
$1.9M 0.06%
30,759
+6,349
+26% +$417K
GNTX icon
390
Gentex
GNTX
$4.97B
$1.89M 0.05%
95,777
+825
+0.9% +$15K
VIG icon
391
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.88M 0.05%
22,104
+3,199
+17% +$269K
RY icon
392
Royal Bank of Canada
RY
$291B
$1.88M 0.05%
27,735
-310
-1% -$20.1K
MTN icon
393
Vail Resorts
MTN
$5.32B
$1.87M 0.05%
11,600
SLV icon
394
iShares Silver Trust
SLV
$28B
$1.86M 0.05%
122,976
-134,359
-52% -$2.18M
BSV icon
395
Vanguard Short-Term Bond ETF
BSV
$44.7B
$1.85M 0.05%
23,291
-5,506
-19% -$440K
SYY icon
396
Sysco
SYY
$40.8B
$1.85M 0.05%
33,372
-4,114
-11% -$214K
IAK icon
397
iShares US Insurance ETF
IAK
$508M
$1.84M 0.05%
+31,097
New +$1.75M
CFR icon
398
Cullen/Frost Bankers
CFR
$10.4B
$1.84M 0.05%
20,833
+11,732
+129% +$941K
VTRS icon
399
Viatris
VTRS
$20.4B
$1.84M 0.05%
48,152
-21,326
-31% -$792K
SIRI icon
400
SiriusXM
SIRI
$9.97B
$1.82M 0.05%
41,016
+38,073
+1,294% +$1.66M

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.